Powering ECG monitoring at scale.

Enabling clinicians to diagnose arrhythmias, detect rhythms associated with stroke, and uncover disease earlier.

The Digital Health & AI Awards 2026 shield, Rising Star winnerWinnerRising Star at the Digital Health & AI Awards 2026Cardiometabolic, Obesity & Diabetes category
FDACleared
  • FDA Breakthrough ×2
  • FDA TAP
  • HIPAA

300 million clinical-grade ECGs. Worldwide. Every year.

The next billion ECGs won’t all come from hospitals.

Each one needs to be analyzed. We find the signals that matter. For your health. For your future.

Device-agnostic, automated ECG analytics at scale.

Power your ECG-enabled products and services with our FDA-cleared, award-winning software.

Explore AccurECG 2.0
FDACleared
  • HIPAA
  • Holter monitorsWorn for a day or more
  • Event recordersHeld to the chest when symptoms come
  • Cardiac patchesStuck on, worn for days
  • MCT devicesSent as they record
  • 12-lead devicesRetrospective ECG analysis
The AccurECG beat annotation view: a recording's beat templates beside its full beat list
US states served
hours of ECG analyzed
arrhythmia events identified since launch

Moving beyond arrhythmias.

Transforming the ECG into a broad biomarker to help identify disease earlier, in cardiology and beyond.

Screening for aortic stenosis, using the ECGs patients already have

Earlier detection can open access to effective treatment, improving outcomes and lowering costs.

Read about aortic stenosis

Watching for hyperkalemia from a wearable ECG

Earlier warning of rising potassium can give clinicians time to act before it becomes an emergency.

Read about hyperkalemia

Recognized by leading programs in heart health and medtech.

Mayo Clinic Platform

Selected for Mayo Clinic Platform_Accelerate.

MedTech Innovator

2024 Execution award finalist. AHA’s Heart and Brain Accelerator Track.

MedTech Breakthrough

Best New ECG Technology Solution, 2026.

American Heart Association

Innovators’ Network member, Center for Health Technology & Innovation.